Om

aetherAI Co., Ltd. is a Taiwan-based technology company specializing in digital pathology platforms and artificial intelligence-assisted diagnosis systems for medical imaging. Primarily serving medical institutions, biotech firms, and pharmaceutical companies, it develops web-based solutions that enhance pathological diagnosis through advanced AI integration into clinical workflows. Key products include the aetherSlide digital pathology imaging platform for image management and annotation, aetherAI Hema for bone marrow smear analysis, aetherAI Endo for endoscopic colorectal polyp detection, and aetherAI LDCT for pulmonary nodule identification. These tools leverage deep neural networks and GigaPixel AI technology, holding multiple patents in image processing and machine learning. Founded in 2015 and headquartered in Taipei, aetherAI Co., Ltd. has expanded sales across Taiwan, Japan, and Germany, with revenue growth from NT$37.6 million in 2022 to NT$102 million in 2023, reflecting its rising role in the global medical software and technology services sector within healthcare.

Om

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I AETHERAI CO MED ENDAVU: Køb aetherAI Co ($7803) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i aetherAI Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.